ONMD Quote, Financials, Valuation and Earnings

DarioHealth Corp. has a net margin of -418.64% compared to OneMedNet Corp.'s net margin of -41.48%. OneMedNet Corp.'s return on equity of -- beat DarioHealth Corp.'s return on equity of -41.55%.

OneMedNet Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand DarioHealth Corp. has an analysts' consensus of $18.00 which suggests that it could grow by 80.91%. Given that DarioHealth Corp. has higher upside potential than OneMedNet Corp., analysts believe DarioHealth Corp. is more attractive than OneMedNet Corp..

OneMedNet Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.161, suggesting its more volatile than the S&P 500 by 16.051%.

OneMedNet Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OneMedNet Corp. pays -- of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend.

OneMedNet Corp. quarterly revenues are $177K, which are smaller than DarioHealth Corp. quarterly revenues of $5M. OneMedNet Corp.'s net income of -$741K is higher than DarioHealth Corp.'s net income of -$2.1M. Notably, OneMedNet Corp.'s price-to-earnings ratio is -- while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OneMedNet Corp. is 56.46x versus 5.52x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Mitesco, Inc. has a net margin of -418.64% compared to OneMedNet Corp.'s net margin of -106766.67%. OneMedNet Corp.'s return on equity of -- beat Mitesco, Inc.'s return on equity of --.

OneMedNet Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Mitesco, Inc. has an analysts' consensus of -- which suggests that it could grow by 345.12%. Given that Mitesco, Inc. has higher upside potential than OneMedNet Corp., analysts believe Mitesco, Inc. is more attractive than OneMedNet Corp..

OneMedNet Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Mitesco, Inc. has a beta of 5.563, suggesting its more volatile than the S&P 500 by 456.284%.

OneMedNet Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mitesco, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OneMedNet Corp. pays -- of its earnings as a dividend. Mitesco, Inc. pays out -- of its earnings as a dividend.

OneMedNet Corp. quarterly revenues are $177K, which are larger than Mitesco, Inc. quarterly revenues of $3K. OneMedNet Corp.'s net income of -$741K is higher than Mitesco, Inc.'s net income of -$3.2M. Notably, OneMedNet Corp.'s price-to-earnings ratio is -- while Mitesco, Inc.'s PE ratio is 2.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OneMedNet Corp. is 56.46x versus 22.60x for Mitesco, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Spok Holdings, Inc. has a net margin of -418.64% compared to OneMedNet Corp.'s net margin of 9.46%. OneMedNet Corp.'s return on equity of -- beat Spok Holdings, Inc.'s return on equity of 10.88%.

OneMedNet Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 58.73%. Given that Spok Holdings, Inc. has higher upside potential than OneMedNet Corp., analysts believe Spok Holdings, Inc. is more attractive than OneMedNet Corp..

OneMedNet Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.415, suggesting its less volatile than the S&P 500 by 58.512%.

OneMedNet Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.45% to investors and pays a quarterly dividend of $0.31 per share. OneMedNet Corp. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend.

OneMedNet Corp. quarterly revenues are $177K, which are smaller than Spok Holdings, Inc. quarterly revenues of $33.9M. OneMedNet Corp.'s net income of -$741K is lower than Spok Holdings, Inc.'s net income of $3.2M. Notably, OneMedNet Corp.'s price-to-earnings ratio is -- while Spok Holdings, Inc.'s PE ratio is 16.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OneMedNet Corp. is 56.46x versus 1.96x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Vaso Corp. has a net margin of -418.64% compared to OneMedNet Corp.'s net margin of 7.55%. OneMedNet Corp.'s return on equity of -- beat Vaso Corp.'s return on equity of 9.61%.

OneMedNet Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Vaso Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that OneMedNet Corp. has higher upside potential than Vaso Corp., analysts believe OneMedNet Corp. is more attractive than Vaso Corp..

OneMedNet Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Vaso Corp. has a beta of 0.466, suggesting its less volatile than the S&P 500 by 53.413%.

OneMedNet Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Vaso Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OneMedNet Corp. pays -- of its earnings as a dividend. Vaso Corp. pays out -- of its earnings as a dividend.

OneMedNet Corp. quarterly revenues are $177K, which are smaller than Vaso Corp. quarterly revenues of $22.7M. OneMedNet Corp.'s net income of -$741K is lower than Vaso Corp.'s net income of $1.7M. Notably, OneMedNet Corp.'s price-to-earnings ratio is -- while Vaso Corp.'s PE ratio is 12.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OneMedNet Corp. is 56.46x versus 0.37x for Vaso Corp.. Usually stocks with elevated PS ratios are considered overvalued.